Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDD-3 Vaccine in Metastatic Melanoma
NCT00107159Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2005
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TAPCells in melanoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jan 2005; status: completed.
02
Drugs
TAPCells
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00107159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107159.